Achieving high quality ligand chemistry in protein-ligand crystal structures for drug design

Multifaceted Roles of Crystallography in Modern Drug Discovery

Volumn , Issue , 2015, Pages 165-181

  Smart, Oliver S ^a,b   Bricogne, Gérard ^a  

^a GLOBAL PHASING LTD   (United Kingdom)

^b SmartSci Limited St John s Innovation Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEXATION; COMPUTATIONAL CHEMISTRY; LIGANDS; PROTEINS; X RAY CRYSTALLOGRAPHY;

CHEMOINFORMATICS; COURSE OF ACTION; HIGH QUALITY; LIGAND CHEMISTRY; LIGAND STRUCTURE; PROTEIN LIGANDS; PROTEIN-LIGAND COMPLEXES; X RAY CRYSTAL STRUCTURES;

CRYSTAL STRUCTURE;

EID: 84943372312     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-017-9719_13     Document Type: Chapter

References (44)

1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28(1):235–242
2. Smart OS (2014) Achieving high quality ligand chemistry in protein X-ray structures. Workshop prepared for the “Structural Basis of Pharmacology: Deeper Understanding of Drug Discovery through Crystallography”, Meeting Erice June http://grade.globalphasing.org/tut/erice_workshop/
3. Leach AR, Gillet VJ (2003) An introduction to chemoinformatics. Kluwer Academic Publishers, Dordrecht/Boston
4. Nissink JWM, Murray C, Hartshorn M, Verdonk ML, Cole JC, Taylor R (2002) A new test set for validating predictions of protein-ligand interaction. Proteins 49(4):457–471
5. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785–2791
6. Sharff A, Keller P, Vonrhein C, Smart O, Womack T, Flensburg C, Paciorek W, Bricogne G (2014) Pipedream documentation, version 1.0.Global Phasing Ltd. http://www.globalphasing.com/buster/manual/pipedream/manual/index.html
7. Terwilliger TC, Bricogne G (2014) Continuous mutual improvement of macromolecular structure models in the PDB and of X-ray crystallographic software: the dual role of deposited experimental data. Acta Crystallogr D Biol Crystallogr 70(10):2533–2543 Buster-report. Global Phasing Ltd. https://www.globalphasing.com/buster/wiki/index.cgi? BusterReport
8. Bricogne G, Blanc E, Brandl M, Flensburg C, Keller P, Paciorek W, Roversi P, Sharff A, Smart OS, Vonrhein C, Womack TO (2014) BUSTER version 2.13.Global Phasing Ltd., Cambridge, UK
9. Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC (2010) MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr Sect D: Biol Crystallogr 66:12–21
10. Bruno IJ, Cole JC, Kessler M, Luo J, Motherwell WDS, Purkis LH, Smith BR, Taylor R, Cooper RI, Harris SE, Orpen AG (2004) Retrieval of crystallographically-derived molecular geometry information. J Chem Inf Comput Sci 44(6):2133–2144
11. Allen FH (2002) The Cambridge Structural Database: a quarter of a million crystal structures and rising. Acta Crystallogr Sect B Struct Sci 58:380–388
12. Smart OS, Holstein J, Womack T (2014) Grade documentation. version 1.2.http://www.globalphasing.com/buster/manual/grade/manual/index.html
13. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr Sect D: Biol Crystallogr 66:486–501
14. Kleywegt GJ, Harris MR, Zou JY, Taylor TC, Wahlby A, Jones TA (2004) The Uppsala electron-density server. Acta Crystallogr Sect D: Biol Crystallogr 60:2240–2249
15. Murshudov GN, Skubak P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA, Winn MD, Long F, Vagin AA (2011) REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr Sect D: Biol Crystallogr 67:355–367
16. Golubev AM, Nagem RAP, Neto JRB, Neustroev KN, Eneyskaya EV, Kulminskaya AA, Shabalin KA, Savel’ev AN, Polikarpov I (2004) Crystal structure of alpha-galactosidase from Trichoderma reesei and its complex with galactose: implications for catalytic mechanism. J Mol Biol 339(2):413–422
17. Rupp B (2010) Biomolecular crystallography: principles, practice, and application to structural biology. Garland Science, New York
18. Vonrhein C, Flensburg C, Keller P, Sharff A, Smart O, Paciorek W, Womack T, Bricogne G (2011) Data processing and analysis with the autoPROC toolbox. Acta Crystallogr Sect D: Biol Crystallogr 67:293–302
19. Pozharski E, Weichenberger CX, Rupp B (2013) Techniques, tools and best practices for ligand electron-density analysis and results from their application to deposited crystal structures. Acta Crystallogr Sect D: Biol Crystallogr 69:150–167
20. Mir R, Singh N, Vikram G, Kumar RP, Sinha M, Bhushan A, Kaur P, Srinivasan A, Sharma S, Singh TP (2009) The structural basis for the prevention of nonsteroidal antiinflammatory druginduced gastrointestinal tract damage by the C-lobe of bovine colostrum lactoferrin. Biophys J 97(12):3178–doi:10.1016/j.bpj.2009.09.030
21. Davis AM, St-Gallay SA, Kleywegt GJ (2008) Limitations and lessons in the use of X-ray structural information in drug design. Drug Discov Today 13(19–20):831–doi:10.1016/j. drudis.2008.06.006
22. Fyffe SA, Alphey MS, Buetow L, Smith TK, Ferguson MAJ, Sorensen MD, Bjorkling F, Hunter WN (2006) Reevaluation of the PPAR-beta/delta ligand binding domain model reveals why it exhibits the activated form. Mol Cell 21(1):1–2
23. Afonine PV, Grosse-Kunstleve RW, Echols N, Headd JJ, Moriarty NW, Mustyakimov M, Terwilliger TC, Urzhumtsev A, Zwart PH, Adams PD (2012) Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr Sect D: Biol Crystallogr 68:352–367 Grade Web Server. Global Phasing Ltd. http://grade.globalphasing.org/
24. Smart OS, Womack TO, Flensburg C, Keller P, Paciorek W, Sharff A, Vonrhein C, Bricogne G (2012) Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER. Acta Crystallogr Sect D: Biol Crystallogr 68:368–380
25. Liebeschuetz J, Hennemann J, Olsson T, Groom CR (2012) The good, the bad and the twisted: a survey of ligand geometry in protein crystal structures. J Comput Aided Mol Des 26(2):169–183
26. Malinina L, Malakhova ML, Kanack AT, Lu M, Abagyan R, Brown RE, Patel DJ (2006) The liganding of glycolipid transfer protein is controlled by glycolipid acyl structure. PLoS Biol 4(11):1996–2011
27. He X, Alian A, Stroud R, de Montellano PRO (2006) Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. J Med Chem 49(21):6308–6323
28. Wlodek S, Skillman AG, Nicholls A (2006) Automated ligand placement and refinement with a combined force field and shape potential. Acta Crystallogr Sect D: Biol Crystallogr 62:741– 749
29. Kim HG, Tan L, Weisberg EL, Liu FY, Canning P, Choi HG, Ezell SA, Wu H, Zhao Z, Wang JH, Mandinova A, Griffin JD, Bullock AN, Liu QS, Lee SW, Gray NS (2013) Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor. ACS Chem Biol 8(10):2145– 2150
30. Kim HG, Tan L, Weisberg EL, Liu FY, Canning P, Choi HG, Ezell S, Zhao Z, Wu H, Wang JH, Mandinova A, Bullock AN, Liu QS, Lee SW, Gray NS (2014) Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor (vol 8, pg 2145, 2013). ACS Chem Biol 9(3):840
31. Hars U, Horlacher R, Boos W, Welte W, Diederichs K (1998) Crystal structure of the effectorbinding domain of the trehalose-repressor of Escherichia coli, a member of the LacI family, in its complexes with inducer trekalose-6-phosphate and noninducer trehalose. Protein Sci 7(12):2511–2521
32. Feng ZK, Chen L, Maddula H, Akcan O, Oughtred R, Berman HM, Westbrook J (2004) Ligand Depot: a data warehouse for ligands bound to macromolecules. Bioinformatics 20(13):2153–2155
33. Dimitropoulos D, Ionides J, Henrick K (2006) Using MSDchem to search the PDB ligand dictionary. Current protocols in bioinformatics/editorial board, Andreas D Baxevanis [et al] Chapter 14:Unit14.13
34. Kabsch W (2010) XDS. Acta Crystallogr Sect D: Biol Crystallogr 66:125–132
35. Brunger AT (1992) Free R-value – a novel statistical quantity for assessing the accuracy of crystal-structures. Nature 355(6359):472–475
36. Scapin G, Patel SB, Lisnock J, Becker JW, LoGrasso PV (2003) The structure of JNK3 in complex with small molecule inhibitors: structural basis for potency and selectivity. Chem Biol 10(8):705–712
37. Davis AM, Teague SJ, Kleywegt GJ (2003) Application and limitations of X-ray crystallographic data in structure-based ligand and drug design. Angew Chem Int Ed 42(24):2718–2736
38. Kleywegt GJ (2007) Crystallographic refinement of ligand complexes. Acta Crystallogr Sect D: Biol Crystallogr 63:94–100
39. Joosten RP, Womack T, Vriend G, Bricogne G (2009) Re-refinement from deposited X-ray data can deliver improved models for most PDB entries. Acta Crystallogr Sect D: Biol Crystallogr 65:176–185
40. Malde AK, Mark AE (2011) Challenges in the determination of the binding modes of nonstandard ligands in X-ray crystal complexes. J Comput Aided Mol Des 25(1):1–12
41. Warren GL, Do TD, Kelley BP, Nicholls A, Warren SD (2012) Essential considerations for using protein-ligand structures in drug discovery. Drug Discov Today 17(23–24):1270–1281
42. Reynolds CH (2014) Protein-ligand cocrystal structures: we can do better. ACS Med Chem Lett 5(7):727–729
43. Read RJ, Adams PD, Arendall WB, Brunger AT, Emsley P, Joosten RP, Kleywegt GJ, Krissinel EB, Lutteke T, Otwinowski Z, Perrakis A, Richardson JS, Sheffler WH, Smith JL, Tickle IJ, Vriend G, Zwart PH (2011) A new generation of crystallographic validation tools for the protein data bank. Structure 19(10):1395–1412
44. Joosten RP, Joosten K, Murshudov GN, Perrakis A (2012) PDB_REDO: constructive validation, more than just looking for errors. Acta Crystallogr Sect D: Biol Crystallogr 68:484–496